Marvin Konstam

Marvin Konstam

Company: CCS

Job title: Founder & Chief Scientific Officer

Seminars:

Therapeutics in Heart Failure: Is HFpEF Really the Target? 9:30 am

Status report on therapeutics in HFpEF: comparison with HFrEF and lessons from SGLT2i’s Stratifying patients with HFpEF: Which phenotype? Which disease? Targeting the treatment population with consideration of metabolic CV disease. Implications for clinical trial design.Read more

day: Day One

Moderated Discussion – Understanding HFpEF 10:00 am

Are we able to define the HFpEF patient? Is HFpEF heterogeneous or is our understanding incomplete? Is there a unifying hypothesis?Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.